Exploring the value of the PRECISE-DAPT score after complex percutaneous coronary intervention to inform dual antiplatelet therapy duration decision-making.

Back

ESC Premium Access

Exploring the value of the PRECISE-DAPT score after complex percutaneous coronary intervention to inform dual antiplatelet therapy duration decision-making.

Session: ACS diagnosis and treatment

Topic: Pharmacotherapy

Speaker: Doctor F. Costa (Messina, IT)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Francesco Costa

G. Martino University Hospital, Messina (Italy)

0 follower

6 more presentations in this session

Long vs. short dual antiplatelet therapy in ACS patients treated with prasugrel or ticagrelor and coronary revascularization: a propensity score analysis from the RENAMI registry

Speaker: Doctor F. Fioravanti (Milan, IT)

Access

Abstract

Slides

The effect of PCI complexity on the efficacy and safety of dabigatran dual therapy vs warfarin triple therapy in atrial fibrillation: a subgroup analysis from the RE-DUAL PCI trial

Speaker: Doctor C. Cannon (Boston, US)

Access

Abstract

Slides

Diagnostic evaluation of a new high-sensitive point-of-care troponin I assay

Speaker: Doctor N. Soerensen (Hamburg, DE)

Access

Abstract

Slides

Diagnostic accuracy of high sensitive cardiac troponin T in patients with suspected acute coronary syndrome and severe chronic kidney disease

Speaker: Doctor B. Alushi (Munich, DE)

Access

Abstract

Slides

Does complying guidelines matter?

Speaker: Doctor I. Campos (Braga, PT)

Access

Abstract

Slides

Access the full session

ACS diagnosis and treatment

Speakers: Doctor F. Costa, Doctor F. Fioravanti, Doctor C. Cannon, Doctor N. Soerensen, Doctor B. Alushi...

Access

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources